Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer

Author:

Horn Leora12,Wang Ziping3,Wu Gang4,Poddubskaya Elena56,Mok Tony7,Reck Martin8,Wakelee Heather9,Chiappori Alberto A.10,Lee Dae Ho11,Breder Valeriy12,Orlov Sergey13,Cicin Irfan14,Cheng Ying15,Liu Yunpeng16,Fan Yun17,Whisenant Jennifer G.1,Zhou Yi18,Oertel Vance19,Harrow Kim1920,Liang Chris21,Mao Li2223,Selvaggi Giovanni22,Wu Yi-Long24

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

2. Now with Global Clinical Head for Lung Cancer and Lung Cancer Strategy, AstraZeneca, Nashville, Tennessee

3. Department of Thoracic Medical Oncology, Peking University Cancer Hospital and Institute, Beijing, China

4. Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

5. Clinical Center for Oncology, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

6. Clinical Center VitaMed, Moscow, Russia

7. Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China

8. Lung Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany

9. Department of Medicine, Division of Oncology and Stanford Cancer Institute, Stanford University, Stanford, California

10. Thoracic Oncology Program, Moffitt Cancer Center, Tampa, Florida

11. Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea

12. Department of Chemotherapy No. 17, N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

13. Department of Biochemistry, Pavlov First Saint Petersburg State Medical University, St Petersburg, Russia

14. Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey

15. Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China

16. Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China

17. Thoracic Tumor Center, Zhejiang Cancer Hospital, Hangzhou, China

18. Biometrics, Xcovery Holdings Inc, Palm Beach Gardens, Florida

19. Clinical Operations, Xcovery Holdings Inc, Palm Beach Gardens, Florida

20. Now with EQRx, Cambridge, Massachusetts

21. Clinical Science, Xcovery Holdings Inc, Palm Beach Gardens, Florida

22. Clinical Development, Xcovery Holdings Inc, Palm Beach Gardens, Florida

23. Now with Sino Biopharmaceutical Ltd, Beijing, China

24. Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3